Lyons, France

Catherine Vidal

USPTO Granted Patents = 4 


Average Co-Inventor Count = 4.5

ph-index = 1


Company Filing History:


Years Active: 2010-2014

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Catherine Vidal: Innovator in Pharmaceutical Chemistry

Introduction

Catherine Vidal is a prominent inventor based in Lyons, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating various medical conditions. With a total of 4 patents to her name, her work has had a substantial impact on the industry.

Latest Patents

Catherine's latest patents include innovative compounds and processes. One of her notable inventions involves hydroxyphenol derivatives, which are used in pharmaceutical compositions for the treatment of dyslipidaemia, atherosclerosis, and diabetes. This patent outlines the processes for preparing these compounds and their therapeutic uses. Another significant patent focuses on specific caspase-10 inhibitors, which are compounds designed to treat diabetic retinopathy. These inventions showcase her expertise in creating effective solutions for complex health issues.

Career Highlights

Catherine Vidal is currently associated with Merck Patent GmbH, where she continues to advance her research and development efforts. Her work has been recognized within the scientific community, and she has established herself as a leading figure in her field.

Collaborations

Catherine has collaborated with esteemed colleagues, including Claude Lardy and Marc Lecomte. These partnerships have further enriched her research and contributed to the success of her inventions.

Conclusion

Catherine Vidal's innovative work in pharmaceutical chemistry exemplifies her dedication to improving health outcomes through scientific research. Her patents reflect her commitment to addressing critical medical challenges, making her a valuable contributor to the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…